ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2013

Oct 7, 2013

SEC Form 4/A — Form 4/A

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2013-08-13

Reporting Person: Cormack Scott Daniel (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-19	Common Stock	S	3112	$8.68	Disposed	60238	Direct

Footnotes

F1: This amended Form 4 is filed to correct the transaction date, which was previously inadvertently reported as August 13, 2013.

F2: This amended Form 4 is filed to correct the transaction code, which was previously inadvertently reported as "F", and the sales price. The sales reported on this amended Form 4 were made for the sole purpose of covering the reporting person's tax liability in connection with the settlement of RSUs on August 19, 2013, which transaction was previously reported.

F3: This amended report is filed to correct the number of shares disposed of in connection with the sale of shares to satisfy the reporting person's tax liability in connection with the vesting of RSUs on August 13, 2013, which transaction was previously reported.